Pharma: Clinic Roundup
Almirall SA, of Barcelona, Spain, said the European Respiratory Journal published full results of ATTAIN (Aclidinium To Treat Airway obstruction In COPD patieNts), a six-month pivotal study comparing the efficacy and safety of twice-daily inhaled aclidinium (200 mcg and 400 mcg) against placebo in patients with moderate to severe chronic obstructive pulmonary disease.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST